Abstract. In canine ventricular myocardium, endothelin-1 (ET-1) alone induced only a weak transient negative inotropic effect (NIE). However, ET-1 induced a marked sustained positive inotropic effect (PIE) subsequent to a transient NIE in the presence of norepinephrine (NE) at low concentrations (0.1 -1 nM) and elicited a pronounced sustained NIE in the presence of NE at high concentrations (around 100 nM). Thus, the extent of b-adrenoceptor stimulation induced by NE played a crucial role in determining the characteristics of the inotropic effects of ET-1. The characteristics of ET receptor subtypes involved in contractile regulation and Ca 2+ signaling induced by ET-1 were determined. The ET-1-induced transient NIE and decrease in Ca transients were abolished by the selective ET A -receptor antagonist FR319317, but not by the selective ET B -receptor antagonist BQ-788. The sustained PIE and the increase in Ca 2+ transients induced by ET-1 were abolished by FR319317, but not inhibited by BQ-788. In contrast, the sustained NIE of ET-1 was abolished by the non-selective ET antagonist TAK-044, markedly attenuated by FR319317, and partially inhibited by BQ-788. ET-1 alone elicited a PIE in the presence of BQ-788, which indicates that the activation of ET B -receptors counteracts the development of the PIE of ET-1. The current findings indicate that both ET A and ET B receptors are involved in the regulation of Ca 2+ signaling and contractility in canine ventricular myocardium.
Introduction
Endothelin-1 (ET-1) is a potent vasoactive peptide of 21 amino acids that was originally isolated from the culture medium of porcine aortic endothelial cells (1) . It has been shown that ET-1 plays a crucial role in regulation of cardiac function under various cardiovascular disorders (2 -5) . Specific high-affinity binding sites for ET-1 are densely distributed throughout various organs, which are classified into ET A and ET B receptors. Whereas it is true that ET A receptors exist mainly on vascular smooth muscle cells and ET B receptors are on endothelial cells, it became evident that ET receptors are distributed in various types of cells in a more complex manner (2 -7). They are expressed also in myocardial cells and high density specific binding sites for [
125 I]ET-1 are found in membrane fractions derived from mammalian ventricular muscle including the dog (8 -10) .
ET-1 exerts a positive inotropic effect (PIE) in association with a negative lusitropic effect in cardiac muscle of most mammalian species, but not in canine ventricular myocardium (9) . In canine ventricular myocardium, however, ET-1 elicits complex inotropic effects by crosstalk with norepinephrine (NE) (11, 12) . Furthermore the detailed investigation revealed that there is a small transient negative inotropic effect (NIE) preceding the sustained PIE in the absence as well as presence of low concentrations of NE (11, 13) . The signal transduction subsequent to ET receptors involves activation of several subcellular mechanisms, including stimulation of protein kinase C (PKC) and protein kinase G that leads to modulation of ion channels and transporters (11) . These processes finally result in alteration of Ca 2+ transients and / or myofilament Ca 2+ sensitivity (11, 12) . ET-receptor subtypes involved in contractile regulation in canine ventricular myocardium have not yet been fully determined (11, 12, 14) . Namely, little is known about the subtypes mediating the transient NIE and sustained PIE.
The present study was designed to clarify ET-receptor subtypes that are responsible for the inotropic effects of ET-1 alone and induced by crosstalk with NE. For this purpose, we investigated the influence of FR139317, a selective ET A -receptor antagonist; BQ-788, a selective ET B -receptor antagonist; and TAK-044, a non-selective antagonist, on the ET-1-induced modulation of contractility and Ca 2+ transients in canine ventricular myocardium.
Materials and Methods
This study was conducted in accordance with Guiding Principles for the Care and Use of Laboratory Animals approved by The Japanese Pharmacological Society and the Guidance for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication No. 85-23, revised 1996) . The approval for the animal experiments was obtained from the Committee for Animal Experimentation, Yamagata University School of Medicine prior to the experiments, and the study was carried out also in accordance with the Declaration of Helsinki.
Measurements of inotropic effects in trabeculae
Mongrel dogs (7 -10 kg) of either sex were used in these experiments. Experiments were carried out as described previously (9 -12) . Preparations of canine ventricular trabeculae had the average dimension of 14.02 ± 2.19 mm in length and 0.85 ± 0.09 mm 2 in crosssectional area (n = 77, from 16 dogs). In all experiments, the a -adrenoceptor antagonist prazosin (300 nM) was allowed to act for 30 min before the addition of NE or ET-1 to exclude the potential involvement of a -adrenoceptor stimulation, and it was present in the organ bath throughout the experiments.
In a series of experiments, influence of the selective ET A -receptor antagonist FR139317 at 1 m M, the selective ET B -receptor antagonist BQ-788 at 1 m M, and the non-selective ET-receptor antagonist TAK-044 at 1 mM on the inotropic effects of ET-1 was studied, in which the inotropic effects of ET-1 in the presence of different concentrations of NE were determined in the absence and presence of these ET-receptor antagonists. The first response to NE was determined for 60 min, NE was then washed out for 60 min, and then it was added again and allowed to act for 15 min before the addition of ET-1. ET-1 was administered at a single concentration to each preparation. The ET-receptor antagonists were administered 20 min before the second addition of NE and were present in the organ bath throughout the experiments.
Measurements of Ca
2+ transients and cell shortening in indo-1-loaded myocytes Canine ventricular cardiac myocytes were obtained by the previously described procedure (14) . Briefly, a portion of the left ventricular free wall that is supplied with the branch of left anterior descending artery was excised, and the artery was then cannulated and perfused for approximately 2 min at 37°C by means of Langendorff methods with Tyrode's solution to wash out the blood. The tissue was then perfused with nominally Ca 2+ free Tyrode's solution for 8 min at rate of about 40 ml / min. The perfusion solution was changed nominally to Ca 2+ -free Tyrode's solution that contained 1.0 mg / ml collagenase and 0.1 mg / ml protease, and the perfusion was continued for 15 -20 min at a perfusion rate of 20 ml / min by use of a recirculating system. Finally the muscle piece was perfused with Tyrode's solution that contained 0.2 mM CaCl 2 and was cut into small pieces with a scalpel. The cell suspension was rinsed several times with a gradual increase in Ca 2+ concentration up to 1.8 mM.
Myocytes were loaded with a fluorescent dye acetoxymethylester of indo-1 (indo-1 / AM) by incubating them in 5 mM indo-1 solution for about 3 min at room temperature (25°C). After loading, they were centrifuged at 5´g for 1 min, and the pellet was resuspended in HEPES-Tyrode's solution. The myocytes were then laid in the chamber superfused for about 10 min with bicarbonate buffer that contained: 116.4 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO 4 , 1.8 mM CaCl 2 , 1.0 mM NaH 2 PO 4 , 5.0 mM glucose, and 23.8 mM NaHCO 3 (pH 7.4) and had been equilibrated with 95% O 2 and 5% CO 2 .
The myocytes were laid in a perfusion chamber placed on the stage of an inverted microscope (Diaphot TMD 300; Nikon, Tokyo). After 10 min when the cells settled down to attach loosely to the bottom of the chamber, the perfusion was started with bicarbonate buffer containing 1.8 mM CaCl 2 at a rate of 1 ml/ min at room temperature (approximately 25°C) and the cells were stimulated electrically by square-wave pulses with voltage about 30 -40% above the threshold at a frequency of 0.5 Hz.
Fluorescence of indo-1 was excited with the light from a xenon lamp (150 W) at a wavelength of 355 nm, reflected by a 380-nm long-pass dichroic mirror (Omega Optical, Brattleboro, VT, USA), and detected by a fluorescence spectrophotometer (CAM-230; Japan Spectroscopic Co., Tokyo). Excitation light was applied to myocytes intermittently through a neutral density filter to minimize the photobleaching of indo-1. The emitted fluorescence was collected by an objective lens (CF Fluor DL40, Nikon) and then separated by a 580-nm long-pass dichroic mirror to permit simultaneous measurements of light at both 405-and 500-nm wavelengths through band-pass filters. The emission field was restricted to a single cell with the aid of an adjustable window. The fluorescence ratio (405 / 500 nm) was used as an indicator of [Ca 2+ ] i (15) . Cells were simultaneously illuminated with red light (wavelength above 620 nm) through the normal bright-field illumination optics of the microscope and the brightfield images of a myocyte were collected by an objective lens and first separated by a 580-nm long-pass dichroic mirror (Omega Optical). A bright-field cell image was projected onto a photodiode array of the edge detector (C6294-01; Hamamatsu Photonic K.K., Hamamatsu) with 5-ms temporal resolution and the cell length was monitored simultaneously with indo-1 fluorescence.
After an equilibration period of 40 min, myocytes were perfused with the solution containing the agent examined. When the response of myocytes to the agent applied reached a stable level, the indo-1 fluorescence was measured and then the perfusion was switched to the solution that contained an additional agent. The cell length was continuously measured throughout the experiments, while the fluorescence of indo-1 was monitored intermittently to reduce the quenching. The cell length and Ca 2+ transients were simultaneously recorded at the baseline state and in the presence of the agent when the response had reached a steady level. In the current study, an increase or decrease in cell shortening is considered to reflect qualitatively the PIE or NIE in isometric contractions and is often referred to as PIE or NIE interchangeably without explanation. Prazosin (300 nM) and ET-receptor antagonists were allowed to act for 20 min prior to addition of NE or ET-1 and were present throughout the experiments.
Cell length and fluorescence of indo-1 were stored and displayed by means of a computer (Power Macintosh 8100/ 100AV; Apple Computer, Inc., Cutertino, CA, USA) equipped with an A / D converter (MP-100A; BIOPAC Systems, Inc., Santa Barbara, CA, USA) at 200 Hz and analyzed after low-pass filtering (cutoff frequency of 20 Hz). The data used for statistical analysis were obtained by signal-averaging of five successive tracings of cell shortening and Ca 2+ transients. In the analysis of data, the diastolic cell length and indo-1 fluorescence ratio prior to first application of the agent that was examined in individual experiments were regarded as baseline values in each myocyte, which are assigned to 100%.
Drugs
The drugs used were ET-1 (Peptide Institute, 
Statistics
Experimental values are presented as means ± S.E.M. Significant differences between mean values were estimated by repeated-measures analysis of variance and/ or by Student's t-test with analytic software STATVIEW J-4.5 (Abacus Concepts, Berkeley, CA, USA). A P value <0.05 was considered to indicate a significant difference between the two means.
Results
Modulation of the inotropic effects of ET-1 by coexisting concentrations of NE in canine ventricular trabeculae ET-1 at 100 nM induced a transient NIE in the absence ( Fig. 1Aa ) and in the presence of a low concentration (1 nM) of NE ( Fig. 1Ab) in canine ventricular trabeculae. The summarized data are presented in Fig. 1B . In the absence as well as in the presence of 1 nM NE, ET-1 induced a small but significant transient NIE (89.2 ± 1.18% in the absence of NE, n = 4, P<0.001; 92.2 ± 1.73% in the presence of NE, n = 6, P<0.001 vs basal force, respectively). ET-1 alone at 100 nM did not induce any PIE (98.9 ± 1.57, n = 4, P>0.05 vs basal force) (Fig. 1Aa) , while in the presence of NE at a subthreshold concentration of 1 nM, ET-1 elicited a sustained PIE (154.0 ± 6.46, n = 6, P<0.001 vs basal force) ( Fig. 1: Ab and B) . The sustained PIE induced by ET-1 in the presence of 1 nM NE increased the contractile force in a concentration-dependent manner ( As shown in actual tracings in Fig. 1Ac , ET-1 at 10 nM elicited a marked sustained NIE in the presence of NE at a high concentration of 100 nM. Summarized data are shown in Fig. 1C . The PIE of NE alone declined gradually and significantly (P<0.05) to 88.2 ± 3.76% (n = 13) of the maximal level during the course of 60 min after the first addition in the control (Fig. 1C) . ET-1 at 10 nM elicited a pronounced sustained NIE when it was administered 15 min after the application of NE (Fig. 1C) .
Transient NIE of ET-1 in the absence and presence of NE In single ventricular myocytes, ET-1 at 100 nM did not elicit significant increases in indo-1 ratio and cell shortening by itself (data not shown), but it induced small but significant transient decreases in indo-1 ratio (75.7 ± 2.18%, n = 4, P<0.001 vs baseline) and cell shortening (86.4 ± 4.38%, n = 4, P<0.001 vs baseline) as shown as actual tracings in Fig. 2A and summarized data in Fig. 2B .
Summarized data on the influence of ET A -and ET Breceptor blockade on the transient NIE induced by ET-1 at 100 nM are shown in the absence (Fig. 3A) or presence (Fig. 3B ) of NE in canine ventricular trabeculae. The ET A -receptor antagonist FR139317 at 1 mM almost completely inhibited the ET-1-induced transient NIE either in the absence of NE (99.2 ± 0.98%, n = 4, P>0.05 vs basal force) (Fig. 3A) or in the presence of NE (99.7 ± 0.31%, n = 4, P>0.05 vs basal force) (Fig. 3B) . By contrast, the ET B -receptor antagonist BQ-788 had no inhibitory action on the transient NIE induced by ET-1 [88.9 ± 5.79% in the absence of NE, n = 5, P<0.001 (Fig. 3A) ; 81.96 ± 3.36% in the presence of NE, n = 5, P<0.001 (Fig. 3B) ; vs basal force.
Since various protein kinase inhibitors suppressed the sustained PIE induced by crosstalk of ET-1 with NE (8, 10, 12, 13), we investigated the influence of these inhibitors on the transient NIE of ET-1 at 100 nM. Figure 3C shows the influence of the inhibitors of protein tyrosine kinase (PTK), Rho kinase (ROK), PI-3 kinase (PI-3K), and MLC kinase (MLCK) on the ET-1-induced transient NIE in the presence of NE at 1 nM. Sustained PIE of ET-1 induced by crosstalk with NE at low concentrations
In ventricular myocytes, ET-1 at 10 nM did not significantly affect the indo-1 ratio (101.1 ± 1.33%, n = 5, P>0.05 vs baseline) and cell shortening (98.8 ± 1.74%, n = 5, P>0.05 vs baseline) by itself, but in the presence of 0.1 nM NE that had no effect on the indo-1 ratio (100.9 ± 2.48%, n = 6, P>0.05 vs baseline) and cell shortening (101.6 ± 2.08%, n = 6, P>0.05 vs baseline), ET-1 induced a sustained increase in cell shortening (134.7 ± 5.70%, n = 5, P<0.001 vs baseline) in association with a small but significant increase in indo-1 ratio (115.8 ± 6.53%, n = 5, P<0.01 vs baseline) (actual tracings in left panel of Fig. 5A and summarized data in left columns of Fig. 5B ).
FR139317 at 1 mM almost completely inhibited the ET-1-induced sustained PIE (100.8 ± 0.64%, n = 6, P<0.001 vs NE + 10 nM ET-1; 103.0 ± 1.12%, n = 4, P<0.001 vs NE + 100 nM ET-1), as shown in Fig. 4 , A and C (time course) and in Fig. 4 , B and D (steady state values). By contrast, BQ-788 at 1 mM had no inhibitory action on the ET-1-induced sustained PIE [114.7 ± 2.78%, n = 4, P>0.05 vs NE + 10 nM ET-1 (Fig. 4B) ; 150.6 ± 12.71%, n = 5, P>0.05 vs NE + 100 nM ET-1 (Fig. 4D) ]. TAK-044 at 1 mM also completely inhibited the sustained PIE induced by 10 nM ET-1 (103.8 ± 0.51%, n = 3, P<0.001 vs NE + 10 nM ET-1) as shown in Fig. 4, A and B .
In ventricular myocytes, FR139317 at 1 mM almost completely inhibited the ET-1-induced increase in the amplitude of indo-1 ratio and cell shortening (105.3 ± 1.70%, n = 4, P>0.05 vs baseline; 101.2 ± 2.98%, n = 4, P>0.05 vs baseline), respectively, as shown as actual tracings in the right panel in Fig. 5A and the summarized data in the right columns in Fig. 5B .
Sustained NIE of ET-1 induced by crosstalk with NE at high concentrations
In ventricular myocytes, NE at 30 nM increased significantly the cell shortening (188.7 ± 15.52%) and the indo-1 ratio (163.0 ± 8.96%) (left columns in Fig. 6 ). ET-1 inhibited significantly the increases induced by NE (cell shortening: 124.0 ± 11.27%, P<0.001; indo-1 ratio: 121.9 ± 9.51%; P<0.001 vs the NE-induced control responses, respectively) (right columns in Fig. 6 ).
As shown in Fig. 7A (time course) and Fig. 7B  (steady state) , in the presence of FR139317, BQ-788, or TAK-044, the NIEs 45 min after the addition of 10 nM ET-1 were 87.7 ± 1.06% (n = 4), 48.8 ± 8.97% (n = 5), and 85.1 ± 3.77% (n = 4) of the maximal response to NE, respectively, which were significantly smaller than the control NIE induced by ET-1 (35.26 ± 4.01%, n = 13). The levels of contractile force at 45 min after the administration of ET-1 in the presence of FR139317 and TAK-044 were not significantly different from the control NE-induced response, indicating that both ETreceptor antagonists abolished the NIE of ET-1 (Fig. 7B) . However, the time course after addition of ET-1 implies that the extent of inhibition induced by FR139317 is less than that by TAK-044 in the early phase after the administration (Fig. 7A) . This difference may be due to the NIE mediated by ET B receptors, since BQ-788 suppressed partially the sustained NIE of ET-1 (Fig. 7: A and B) .
Sustained PIE of ET-1 alone under ET B -receptor blockade with BQ-788
While ET-1 did not increase significantly the basal force of contraction by itself, in the presence of the ET B -receptor antagonist BQ-788 at 1 m M, ET-1 induced a significant sustained PIE at 10 nM (Fig. 8: A and B ; 7 . Influence of FR139317, BQ-788, and TAK-044 on the NIE induced by 10 nM ET-1 in the presence of 100 nM NE in isolated canine ventricular trabeculae. A: influence of FR139317, BQ-788, and TAK-044 on the time course of the ET-1-induced NIE in the presence of 100 nM NE. The maximal response to 100 nM NE before the addition of ET-1 was assigned to 100% for each preparation, and the changes in force of contraction are expressed as a percentage of the control NE-induced response. B: summarized data on panel A determined at the maximal steady levels in each series. FR: FR139317 (1 mM), BQ: BQ-788 (1 mM), TAK: TAK-044 (1 m M). Basal force of contraction and maximal increase in force induced by 100 nM NE were 7.80 ± 1.44 mN/ mm and 12.28 ± 2.02 mN /mm (n = 13), respectively. Presented are means ± S.E. of the mean. Numbers in parentheses indicate the number of muscle preparations. ***P<0.001 vs the control response to NE; # P<0.05, ### P<0.001 vs the response to ET-1 + NE in the absence of ET-receptor antagonists. Experiments were carried out in the presence of 300 nM prazosin.
116.9 ± 4.32, n = 5, P<0.001 vs basal force) and at 100 nM (Fig. 8: C and D; 152.2 ± 19.71, n = 5, P<0.001 vs basal force). In contrast, in the presence of FR139317, ET-1 at 100 nM did not affect the basal force of contraction (99.9 ± 1.26%, n = 4).
Discussion
In the canine ventricular myocardium, ET-1 alone elicited only a small transient NIE, but the inotropic effect of ET-1 is markedly dependent on the concentration of co-existing NE. ET-1 induced a transient and sustained NIE and sustained PIE, the latter two of which were due to the crosstalk with NE as a b-adrenoceptor agonist, and are mediated by different ET receptor subtypes and signaling pathways.
ET-1 alone and ET-1 in the presence of low concentrations of NE close to the threshold concentration (0.1 - 1 nM) elicited a transient NIE preceding to a sustained PIE, both of which were mediated by ET A receptors that were susceptible to FR139317, but not to the ET B antagonist BQ-788. On the other hand, the sustained NIE of ET-1 in the presence of high concentrations of NE (around 100 nM) are mediated mainly by ET A receptors, but ET B receptors also contribute in part to the sustained NIE.
Transient NIE induced by ET-1 in the absence and presence of NE It should be noted that the concentration of ET-1 (30 -100 nM) employed in the current study is high enough to achieve the maximal positive inotropic response in canine ventricular myocardium and myocytes (11, 16, 17) . We chose these concentrations to stimulate effectively most of the receptor subtypes and signal transduction processes potentially involved in the ET-induced inotropic responses. ET-1 at 100 nM induced a small but significant transient NIE, either in the presence or absence of NE, indicating that the transient NIE of ET-1 does not require the crosstalk with b-adrenoceptor agonists. The transient NIE was associated with a definite decrease in Ca 2+ transients (Fig. 2) , which is an indication that it is mainly due to a decrease in intracellular Ca 2+ mobilization induced by ET-1. The transient NIE was completely inhibited by FR130317, but not by BQ788, indicating that it is exclusively mediated by ET A receptors. Neither genistein, Y-27632, nor wortmannin that inhibited the ET-1-induced sustained PIE (11, 13, 18, 19) affected the transient NIE of ET-1, indicating that it may not involve activation of protein kinases, including protein tyrosine kinase, Rho kinase, PI3 kinase, and MLC kinase. The transient NIE of ET-1 was elicited also in rabbit (13, 20, 21) and mouse (22, 23) cardiomyocytes, which may be due to the inhibitory action of ET-1 on L-type Ca 2+ currents (I Ca(L) ) (24) .
Sustained PIE of ET-1 induced by crosstalk with NE at low concentrations
In canine ventricular myocardium, ET-1 elicits a PIE in the presence of NE at subthreshold concentrations (0.1 -1 nM) (11, 12, 16, 17) . The characteristic feature of the sustained PIE of ET-1 is that it is induced by combination of increases in intracellular Ca 2+ mobilization and myofilament Ca 2+ sensitivity. Furthermore, pharmacological analysis implies that the sustained PIE requires activation of both PKC and PKA (11, 12, 16, 17) . Either timolol or H-89 was able to inhibit the sustained PIE of ET-1, which is an indication that a small extent of cyclic AMP accumulation caused by weak b-adrenoceptor stimulation may be involved in an increase in myofilament Ca 2+ sensitivity induced by crosstalk of ET-1 with NE in canine ventricular myocardium. The current study revealed that the ET receptor subtype involved in the sustained PIE is susceptible to the selective ET A antagonist FR139317, but not to the ET B antagonist BQ-788.
Sustained NIE induced by crosstalk of ET-1 with NE at high concentrations: anti-adrenergic effect of ET-1 ET-1 (10 nM) administered during induction of the PIE by NE at 100 nM inhibited the NE-induced PIE, which is similar to the well-established anti-adrenergic action of ACh and adenosine in mammalian ventricular myocardium (25 -27) . The sustained NIE of ET-1 is elicited in most mammalian species, including guinea pig (28, 29) , rat (28), rabbit (24) , and dog (14, 30) . Effectiveness of selective ET A antagonists to inhibit the inhibitory effect of ET-1 on the NE-induced PIE in the current study is consistent with the previous findings that ET A antagonists suppressed the inhibitory action of ET-1 on the b-mediated increase in I Ca(L) currents in guinea pig (31, 32) , rabbit (24) , and dog (14) ventricular cardiomyocytes. In addition, the present study revealed that the inhibitory effect of ET-1 on the NE-induced PIE was partially attenuated by BQ-788, indicating that ET B receptors also contribute to the anti-adrenergic effect of ET-1, which is consistent with the previous finding that the activation of ET B receptors contributes to the ET-1-induced inhibition of b-adrenoceptormediated increase in I Ca(L) currents in rabbit (24) and dog (14) ventricular cardiomyocytes.
The subcellular mechanism for the ET-1-induced antiadrenergic effect, however, is different from that for the muscarinic cholinergic effect. The inhibition of adenylyl cyclase activity and subsequent accumulation of cAMP may not be responsible for the ET-1-induced sustained NIE in the dog (12) . Instead, the activation of phosphatase that dephosphorylates the PKA-mediated phosphorylation of regulatory proteins is considered to be crucial for the mechanism of the anti-adrenergic effect of ET-1 (11, 33, 34) . Activation of PKC by ET-1 is not involved in the anti-adrenergic effect of ET-1 either (11, 24) .
Sustained PIE of ET-1 under ET B -receptor blockade by BQ-788
The ET B -receptor blockade by BQ-788 unmasked the PIE of ET-1 even in the absence of NE (Fig. 8) , which is an indication that the activation of ET B receptors that results in an inhibitory action is partially responsible for the absence of PIE of ET-1 in the canine ventricular myocardium, which is consistent with the previous findings in I Ca(L) current in rabbit ventricular cardio-myocytes (24) and mouse heart (35) . ET-1 may activate receptor subtypes that trigger both positive and negative inotropic responses, the latter being more susceptible to the antagonistic action of BQ-788. It is noteworthy that the inhibitory action does not share the signaling process with the transient NIE, while it might be elicited via the same signaling mechanism for the sustained NIE, which requires, however, further study.
Another potential mechanism that ET B receptors act as clearance receptors, the inhibition of which increases the ET-1 concentration to bind ET A receptors, may be responsible for the enhanced PIE of ET-1 (36, 37) . However, this appears to be unlikely because ET-1 alone never induces a PIE even at very high concentrations.
It is noteworthy that the extent of b-adrenoceptor stimulation induced by NE played a crucial role in determining the inotropic response to ET-1 in canine ventricular myocardium (11) . The antagonistic action of ET-1 on the cyclic AMP-mediated cardiac facilitation including an increase in L-type Ca 2+ current and positive chronotropic and inotropic effects has been well documented (12, 14, 24, 28 -32, 34) . The observation that the sustained PIE of ET-1 is partly due to an increase in myofilament Ca 2+ sensitivity is of extreme interest with respect to the effect requiring a weak b-adrenoceptor stimulation, probably leading to a small extent of cyclic AMP (11), the detailed mechanism of which remains to be clarified in future studies. The induction of the sustained PIE in the presence of weak b-adrenoceptor stimulation by subthreshold concentrations of NE, and the inhibitory action of ET-1 on the cyclic AMP-mediated PIE induced by strong b-adrenoceptor by high concentrations of NE may be of pathophysiological significance in contractile regulation because plasma levels of both ET-1 and NE are elevated in cardiovascular disorders such as heart failure (38 -40) .
In summary, the current study indicates that the ET Areceptor blockade by FR319317 suppresses the transient NIE, sustained PIE, and sustained NIE, the latter two of which are induced by crosstalk of ET-1 with NE, while the ET B -receptor blockade by BQ-788 suppresses partially the sustained NIE. In addition, BQ-788 unmasks the PIE of ET-1 in the absence of NE in canine ventricular myocardium.
